The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so it's not unusual for a clinical development plan for a vaccine today year to year sometimes three years to go through the series of phase one trials for safety and then graded trials for Phase two to show that those are expanded safety studies maybe getting a hint of efficacy and then the phase three pivotal study for licensure in an area of transmission
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.